CLINICAL_TRIALS
withdrawal
· 2024-12-20
Clinical Trial Update: HBOC-201 Expanded Access Protocol for Life-threatening Anemia for Whom Allogeneic Blood Transfusion is Not an Option
Summary
The HBOC-201 expanded access protocol for life-threatening anemia in patients without viable allogeneic transfusion options is no longer available.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mauricio Lynn | Conditions: Anemia | Status: NO_LONGER_AVAILABLE